Product image of Meloxicam Laropharm (Meloxicam) supplied by GNH India

Meloxicam Laropharm

Active Ingredient:
Meloxicam
Origin:
EU

Meloxicam Laropharm (Meloxicam)

Meloxicam, the active ingredient in Meloxicam Laropharm, is a nonsteroidal anti-inflammatory drug (NSAID) presented as a tablet for oral use. It is indicated for the management of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute pain in adult patients. GNH India supplies Meloxicam Laropharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Laropharm Srl

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Meloxicam is an NSAID that reduces inflammation and pain across several musculoskeletal disorders.
  • Osteoarthritis: alleviates joint pain and improves functional ability.
  • Rheumatoid arthritis: decreases synovial inflammation and slows disease progression.
  • Ankylosing spondylitis: reduces spinal pain and stiffness.
  • Acute pain: provides rapid relief of moderate to severe pain.

How It Works

  • Meloxicam inhibits both cyclooxygenase‑1 (COX‑1) and cyclooxygenase‑2 (COX‑2) enzymes, leading to a reduction in prostaglandin synthesis. By lowering prostaglandin levels, it diminishes inflammation, pain, and fever associated with various rheumatic conditions.

Side Effects

Adverse reactions may vary in frequency and severity.

Common Side Effects

  • Gastrointestinal upset (nausea, dyspepsia)
  • Abdominal pain
  • Diarrhea
  • Headache
  • Dizziness
  • Mild skin rash

Serious or Rare Side Effects

  • Gastrointestinal ulcer or bleeding
  • Cardiovascular events (myocardial infarction, stroke)
  • Elevated liver enzymes or hepatitis
  • Severe skin reactions (Stevens‑Johnson syndrome)
  • Renal impairment or failure
  • Anaphylaxis or severe hypersensitivity

Precautions & Warnings

  • Before initiating therapy, clinicians should consider several safety aspects.
  • Assess renal function: evaluate kidney status and adjust use accordingly.
  • Monitor gastrointestinal risk: avoid in patients with active ulcer disease.
  • Use lowest effective dose: limit exposure to reduce adverse events.
  • Avoid in known hypersensitivity: discontinue if allergic reaction occurs.
  • Review concomitant NSAIDs or anticoagulants: increased bleeding risk.
  • Store at ambient temperature: keep below 25°C in the original pack, protect from moisture.

Avoid Interactions

Meloxicam can interact with several drug classes, requiring careful management.

Major Interactions (Avoid)

  • Warfarin: increased risk of serious bleeding.
  • ACE inhibitors or ARBs: may reduce renal function.
  • Lithium: elevated serum lithium levels.

Moderate Interactions (Monitor Closely)

  • SSRIs: additive bleeding risk.
  • Diuretics: potential electrolyte disturbances.

Frequently Asked Questions

Meloxicam Laropharm is prescribed for osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute pain where inflammation and moderate to severe pain need to be controlled.

Meloxicam works by inhibiting the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which reduces the production of prostaglandins that mediate inflammation, pain, and fever.

The dose is determined by the prescribing clinician based on the patient’s specific condition, severity, and response. The prescriber sets the appropriate regimen for each individual.

Safety in pregnancy and lactation has not been definitively established. It should be used only if the potential benefit justifies the potential risk, and breastfeeding mothers should consult a healthcare professional before use.

Submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India will verify institutional credentials, then reply with pricing, availability, shipping details (including any cold‑chain requirements), and the necessary import paperwork.

Meloxicam offers once‑daily dosing and preferential COX‑2 inhibition, which may lower gastrointestinal risk compared with non‑selective NSAIDs. However, individual response and safety profiles vary, so clinicians choose based on patient factors.

Store the product at room temperature below 25 °C, in the original packaging, protected from moisture and direct sunlight to maintain its stability and potency.

Meloxicam Laropharm is taken orally, usually with or without food, as directed by the prescribing clinician. The tablet should be swallowed whole with an adequate amount of water.

Serious risks include gastrointestinal ulcer or bleeding, cardiovascular events such as heart attack or stroke, severe skin reactions, and renal impairment. Patients should be monitored for signs of these conditions during therapy.

Individuals with known hypersensitivity to meloxicam or other NSAIDs, active gastrointestinal ulceration, severe heart failure, or significant renal or hepatic impairment should avoid using this medication.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Meloxicam

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT